{"name":"Windtree Therapeutics","slug":"windtree-therapeutics","ticker":"","exchange":"","domain":"","description":"Windtree Therapeutics, Inc. is an American company which was set up in 1992 and now is based in Warrington, Pennsylvania, developing drug products for patients with respiratory disease. The company joined an alliance with Laboratorios del Dr. Esteve, S.A. In 2016, Discovery Laboratories changed name to Windtree Therapeutics, Inc.","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":198000,"revenueGrowth":25.3,"grossMargin":0,"rdSpend":16276000,"netIncome":-1787000,"cash":27875000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2019"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOU3FiallzVXNicV9EZm9uZlFybThXYVhxTFU3MGVjLUpXMDFyQzZVRFEyOFJTWi1aQWpneDRMVkswclg5UzRHTUJyQjBwNmFMUldjaFU2UUtweU9zWWZOOG0zMWFRN0xoNGRSSEdNb2stZ3pnRHpMN1M0YURmb3EwSm10V1pSdlAwcU9ld3Nab25nV0FRZ1FHcV9yRFZPNDFyODVyVVp4eHhqZTJt?oc=5","date":"2026-03-30","type":"pipeline","source":"Yahoo Finance","summary":"Panacea Capital Leads Formation of Seismic Pharma to Advance Novel, Clinical-Stage Heart Failure Portfolio - Yahoo Finance","headline":"Panacea Capital Leads Formation of Seismic Pharma to Advance Novel, Clinical-Stage Heart Failure Portfolio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPbWhCM2FXSUFQS0lXT3pqYi1CazBtSTNWbnpPU18xT1NXSHh2d09WZjBhNUJnZVZTSktGb3dHeWRQQWMzcEhwVzBTeWJaX0lWQnRpWUhKbGVlb1dqN2l6cVRvSkwybjFUSEFsaTNuejN3SWFJSnRMUUQ1Yy1lVGdweGxwLTJLMzZ3cFo3YmxvSkVHWDhnNWc?oc=5","date":"2026-02-28","type":"earnings","source":"PHILADELPHIA.Today","summary":"Denmark's Alveus Therapeutics Shifts Headquarters to Philadelphia After Securing $197M in New Funding - PHILADELPHIA.Today","headline":"Denmark's Alveus Therapeutics Shifts Headquarters to Philadelphia After Securing $197M in New Funding","sentiment":"neutral"},{"date":"2026-01-07","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQODRXTzk4QXdfUDlSNG5xZ00wbzBabExCUHIwZ3Nwd3N2aFFleU5yalV2MmhTSVMzdDhnU3hfbnlpQ0d2eURWRjNHMTRGRVFsN2p4amhaWi1qeWlzRU9ILWczUVpaTG43T1ZZaUxNNlVhdkRPWldQdmVOdGFadFI3bnpxZzhQN09QNjBrV3JEZFN6M19QdEFKQlJUTVgtSkFfYndHazFLY3J2SGlpSkMzcFNYUVhKdWVPTG9iNEYwRE9RQ1lrYmNHeg?oc=5","date":"2025-12-23","type":"pipeline","source":"Fierce Biotech","summary":"Windtree offloads cardio pipeline, Vaccinex secures $60M funding in continued holiday shopping spree - Fierce Biotech","headline":"Windtree offloads cardio pipeline, Vaccinex secures $60M funding in continued holiday shopping spree","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxQVXhCMV9MSXN2NVdQVUo1M1VDVnJqWHI4YzNBSzhjN3hlOXZla1M5V1FVd1I5V0lXWExMNzgzdy0xNW5uUXNrVHdLRVlWMk9wOFFnSkpuZ1lnU1NNa212cFl5SVNtaHNheDBaWmZxWnZVOVN5TUNmRXNmQzZkd0ZqbVV0dUtHcExFYXB1QnJzaTNrZ0R1OHZ2TklHX1NqN3lSVTE1T2pxdEppTmdxZW5yNFVPWndYS0JpRk9SX202SG5DNFcwbVJZTEN3ajJsZlV2TFJXbEU1anhURE1TZEQ1TmVpQjdXdDRpT29CVG91RUxKSUxsanNWeEg4NA?oc=5","date":"2025-12-23","type":"pipeline","source":"GlobeNewswire","summary":"Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates - GlobeNewswire","headline":"Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNaFo5b2xUMDhLdTNoRkp3NzItVFZkZnIyaVNHTnV6WDE0T3prNzlyUzRoY181M2FQYmVHb0dqeTZmNkVYWGVoVnhTLXI3VE0yLUtLNVl0TW9xX2xVMjI0WmdWU0RjQ3VXc21OVmNjVk03WS1SUF9VM29UcjFMcXZnT3l6STAwV3NRSzVQVUtSWHBuYVZ5UVM1VWxsM3J6U1NfZG02TF8yOXpXaTFyM1E0TmZySUhmbE5Y?oc=5","date":"2025-12-23","type":"pipeline","source":"Stock Titan","summary":"Heart failure drug lineup sold, but seller keeps a slice of future sales - Stock Titan","headline":"Heart failure drug lineup sold, but seller keeps a slice of future sales","sentiment":"neutral"},{"date":"2025-12-02","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2025-11-19","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: FORM 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2025-10-16","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTFBIS25ScTdSNlVDd21QcHVwcVgyVWVuLU9rQWotT1lzUndSRU5xYUJDXzdja01nWHdjVm0yNGRqU1J5RVNmQnRGN1VPWmlfOVd3SUgwNTRrVndqdm9CQldQVTZVaE5MMzhrMHY3NXF4UTBqRy1zU19WdA?oc=5","date":"2025-10-07","type":"pipeline","source":"BUCKSCO.Today","summary":"Amid Continued Financial Struggles, Warrington’s Windtree Therapeutics Shifts Focus - BUCKSCO.Today","headline":"Amid Continued Financial Struggles, Warrington’s Windtree Therapeutics Shifts Focus","sentiment":"neutral"},{"date":"2025-10-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2025-09-08","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2025-09-02","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE5PM2NGa29yTFFKVnNQVjYtZHNOSlhjeFZwYVNydW1FNVNQMUhjQXZMMERpWTVROEpxLW9aU1JwV0FMVWVnWFVnV3AyOG9vbDdhbDNKUGZhUGlDVTZMNnBzNTJ2VnpWMUFPQUVTcjJTX0s2bHJ5Y0RSMFJn?oc=5","date":"2025-08-28","type":"pipeline","source":"BUCKSCO.Today","summary":"Warrington’s Windtree Therapeutics Faces Uncertain Future After NASDAQ Delisting - BUCKSCO.Today","headline":"Warrington’s Windtree Therapeutics Faces Uncertain Future After NASDAQ Delisting","sentiment":"neutral"},{"date":"2025-08-20","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar","revenue":198000,"revenuePeriod":"2019-12-31","revenueHistory":[{"value":198000,"period":"2019-12-31"},{"value":158000,"period":"2019-06-30"},{"value":40000,"period":"2019-03-31"},{"value":1788000,"period":"2018-12-31"},{"value":304000,"period":"2018-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":16276000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-1787000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":27875000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}